PKM and triple-negative breast carcinoma: In triple-negative breast cancer, methyltransferase 14 (METTL14)-mediated N6-methyladenosine (m6A) modification facilitates PKM2 degradation through the miR-29c-3p/TRIM9 axis, shifting the balance toward the low-activity dimer (30).